文献速递肺结节与肺癌间质性肺疾病

经支气管冷冻活检诊断肺实质病变的安全性与性能

Safety and Performance of Transbronchial Cryobiopsy for Parenchymal Lung Lesions.
PubMed 文献 · Chest · 2021-05-07

结果显示出血发生率18%(临床显著3.5%),气胸6.6%(需胸腔置管6.3%),诊断率91%,腺癌和转移性疾病最常见,安全性可接受。

要点

  • 经支气管冷冻活检诊断肺实质病变的诊断率达91%。
  • 临床显著出血(≥3级)发生率为3.5%,气胸需引流率为6.3%。
  • 所有胸腔引流管均在4天内拔除,无迁延性漏气。

核心结论

  • 经支气管冷冻活检在肺实质病变评估中显示出可接受的安全性和诊断率。

研究设计与样本

  • 所有操作均使用硬质和可弯曲支气管镜联合可弯曲冷冻探头。

主要发现

  • 所有胸腔引流管在4天内拔除,无迁延性漏气病例。
  • 932例(91%)获得明确诊断,最常见为腺癌(46%)和转移性疾病(21%)。

关键数值与推荐

  • 出血按0(微量)至4(需外科干预)分级,≥3级视为临床显著。
  • 诊断率91%,腺癌占46%,转移性疾病占21%。

临床怎么用

  • 对于无支气管内病变的肺实质病变,经支气管冷冻活检可作为获取较大样本并提高诊断率的可行选项。
  • 操作需关注出血和气胸风险,临床显著出血需外科干预级别较低(3.5%),多数气胸需置管引流(6.3%)。

局限性

  • 回顾性研究设计可能存在选择偏倚和信息偏倚。
  • 原文未报告前瞻性验证结果,仅提及前瞻性临床试验正在进行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite advances in technology, the bronchoscopic diagnosis of parenchymal pulmonary lesions (PPLs) remains difficult to achieve. Transbronchial lung cryobiopsy (TLCB) offers the potential for larger samples with improved diagnostic yield; however, a paucity of data exists describing its safety and usefulness for the diagnosis of PPL. RESEARCH QUESTION: What is the safety profile of TLCB for PPL? STUDY DESIGN AND METHODS: An observational, retrospective, multicenter cohort study enrolled patients without endobronchial disease undergoing TLCB of PPL from 2015 through 2019. All procedures were performed using both rigid and flexible bronchoscopy with a flexible cryoprobe. Complication rates, including bleeding and pneumothorax rates, were collected. Bleeding was graded on a scale from 0 (trace) to 4 (requiring surgical intervention) with a grade of ≥ 3 considered clinically significant. Pneumothorax, tube thoracostomy placement, diagnostic yield, and need for subsequent interventions were recorded. RESULTS: One thousand twenty-four patients underwent TLCB. One hundred eighty-eight patients (18%) experienced bleeding; in 36 patients (3.5%), the bleeding was clinically significant. Sixty-eight patients (6.6%) demonstrated a pneumothorax and 64 patients (6.3%) required drainage with tube thoracostomy. All chest drains were removed within 4 days, and no cases of prolonged air leak occurred. A definitive diagnosis was achieved in 932 patients (91%). Adenocarcinoma (46%) and metastatic disease (21%) were the most common diagnoses. INTERPRETATION: TLCB showed an acceptable safety profile and diagnostic yield for the evaluation of PPL in this large retrospective cohort. Prospective clinical trials are underway to validate these findings further.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Herth FJ, Mayer M, Thiboutot J, et al. Safety and Performance of Transbronchial Cryobiopsy for Parenchymal Lung Lesions. Chest. 2021. PMID: 33971147. doi:10.1016/j.chest.2021.04.063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。